InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

CERENOME, INC.

CNSY Clue Score52
United States Fiscal year ends December CIK 0001095981
$1.93 +7.82% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.93 +12.21% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue4.7Operating income−19.7Net income−22.0Fiscal year 2017Revenue2.7 −42.2%Operating income−20.7Net income−22.7Fiscal year 2018Revenue3.7 +36.5%Operating income−8.8Net income−12.6Fiscal year 2019Operating income−3.7Net income−10.9Fiscal year 2020Operating income−9.6Net income−8.2Fiscal year 2021Operating income−12.5Net income−13.4EPS, diluted−1.11Fiscal year 2022Operating income−19.7Net income−20.3EPS, diluted−11.58Fiscal year 2023Revenue4.9Operating income−13.3Net income−13.3EPS, diluted−4.24Fiscal year 2024Revenue5.8 +18.5%Operating income−14.7Net income−13.0EPS, diluted−2.34Fiscal year 2025Revenue5.2 −10.5%Operating income−15.3Net income−22.4EPS, diluted−0.29
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 4.7 2.7 3.7 n/a n/a n/a n/a 4.9 5.8 5.2
Growth −42.2% +36.5% +18.5% −10.5%
Operating income −19.7 −20.7 −8.8 −3.7 −9.6 −12.5 −19.7 −13.3 −14.7 −15.3
Net income −22.0 −22.7 −12.6 −10.9 −8.2 −13.4 −20.3 −13.3 −13.0 −22.4
Growth
EPS, diluted n/a n/a n/a n/a n/a −1.11 −11.58 −4.24 −2.34 −0.29

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin41.7%Operating margin−423.2%Net margin−473.5%Free cash flow margin−421.0%Fiscal year 2017Gross margin5.4%Operating margin−769.2%Net margin−843.7%Free cash flow margin−685.1%Fiscal year 2018Operating margin−238.7%Net margin−344.2%Free cash flow margin−329.8%Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Operating margin−271.1%Net margin−271.0%Free cash flow margin−264.8%Fiscal year 2024Operating margin−252.3%Net margin−222.8%Free cash flow margin−183.7%Fiscal year 2025Operating margin−293.5%Net margin−429.4%Free cash flow margin−399.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 41.7% 5.4% n/a n/a n/a n/a n/a n/a n/a n/a
Operating margin −423.2% −769.2% −238.7% n/a n/a n/a n/a −271.1% −252.3% −293.5%
Net margin −473.5% −843.7% −344.2% n/a n/a n/a n/a −271.0% −222.8% −429.4%
Free cash flow margin −421.0% −685.1% −329.8% n/a n/a n/a n/a −264.8% −183.7% −399.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−19.5Capital expenditure−0.1Free cash flow−19.6Fiscal year 2017Operating cash flow−18.1Capital expenditure−0.3Free cash flow−18.4Fiscal year 2018Operating cash flow−12.0Capital expenditure−0.1Free cash flow−12.1Fiscal year 2019Operating cash flow−5.9Capital expenditure−0.1Free cash flow−6.0Fiscal year 2020Operating cash flow−8.4Fiscal year 2021Operating cash flow−10.3Fiscal year 2022Operating cash flow−13.0Fiscal year 2023Operating cash flow−12.9Capital expenditure−0.2Free cash flow−13.0Fiscal year 2024Operating cash flow−10.6Capital expenditure−0.1Free cash flow−10.7Fiscal year 2025Operating cash flow−20.8Capital expenditure−0.1Free cash flow−20.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −19.5 −18.1 −12.0 −5.9 −8.4 −10.3 −13.0 −12.9 −10.6 −20.8
Capital expenditure −0.1 −0.3 −0.1 −0.1 n/a n/a n/a −0.2 −0.1 −0.1
Free cash flow −19.6 −18.4 −12.1 −6.0 n/a n/a n/a −13.0 −10.7 −20.8
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash12.6Total debt6.6Net cash (debt)6.0Shareholders’ equity11.0Debt to equity0.60Fiscal year 2017Cash9.6Total debt13.6Net cash (debt)−4.1Shareholders’ equity13.0Debt to equity1.05Fiscal year 2018Cash5.3Total debt14.2Net cash (debt)−8.9Shareholders’ equity5.2Debt to equity2.72Fiscal year 2019Cash17.6Total debt11.1Net cash (debt)6.5Shareholders’ equity1.2Debt to equity9.53Fiscal year 2020Cash8.3Total debt6.3Net cash (debt)2.0Shareholders’ equity3.0Debt to equity2.09Fiscal year 2021Cash18.4Total debt6.6Net cash (debt)11.8Shareholders’ equity10.8Debt to equity0.61Fiscal year 2022Cash18.1Total debt5.4Net cash (debt)12.7Shareholders’ equity6.4Debt to equity0.84Fiscal year 2023Cash8.6Total debt4.0Net cash (debt)4.6Shareholders’ equity−1.3Fiscal year 2024Cash0.1Shareholders’ equity−8.9Fiscal year 2025Cash4.3Shareholders’ equity4.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.6 9.6 5.3 17.6 8.3 18.4 18.1 8.6 0.1 4.3
Total debt 6.6 13.6 14.2 11.1 6.3 6.6 5.4 4.0 n/a n/a
Net cash (debt) 6.0 −4.1 −8.9 6.5 2.0 11.8 12.7 4.6 n/a n/a
Shareholders’ equity 11.0 13.0 5.2 1.2 3.0 10.8 6.4 −1.3 −8.9 4.0
Debt to equity 0.60 1.05 2.72 9.53 2.09 0.61 0.84 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Operations
−19.5 −18.1 −12.0 −5.9 −8.4 −10.3 −13.0 −12.9 −10.6 −20.8
Growth
1.2 2.2 2.0 0.9 0.4 0.4 0.6 0.6 0.9 0.4
Investment
−0.1 −0.3 −0.1 −0.1 n/a n/a n/a −0.2 −0.1 −0.1
calc −19.6 −18.4 −12.1 −6.0 n/a n/a n/a −13.0 −10.7 −20.8
Growth
calc n/a n/a n/a n/a n/a n/a n/a −4.14 −1.39 −0.27
n/a −1.4 −0.1 5.6 −0.5 −0.1 −0.8 −0.2 −4.1 −0.9
Financing
n/a 16.8 7.2 12.6 −0.3 20.4 13.5 3.4 6.2 30.3

† The diluted share count jumps at 2022 and 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.